Somatostatin receptors in normal and tumoral tissue.
Somatostatin receptors have been visualized with autoradiography and characterised biochemically in various somatostatin target tissues, such as brain, pituitary, pancreas and gastrointestinal tract, where they are likely to mediate the somatostatin actions. With the same methods, somatostatin receptors have been detected also in tumors originating from somatostatin target tissues: high receptor incidence is found in GH-producing pituitary adenomas as well as in some hormone-producing gastrointestinal tumors. These tumors are often highly responsive to somatostatin analogs in vivo. Among brain tumors, meningiomas usually contain a high density of receptors, suggesting a novel function for somatostatin in the human meninges. Among other human tumors tested, prostate, ovarian and endometrial carcinomas were free of receptors whereas 3 out of 39 mammary tumors contained somatostatin receptors.
D000236:Adenoma / Q000503:physiopathology*; D000818:Animals; D005770:Gastrointestinal Neoplasms / Q000503:physiopathology*; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology; D010911:Pituitary Neoplasms / Q000503:physiopathology*; D017981:Receptors, Neurotransmitter / Q000502:physiology*; D017481:Receptors, Somatostatin; D013004:Somatostatin / Q000502:physiology*
D017981:Receptors, Neurotransmitter; D017481:Receptors, Somatostatin; D013004:Somatostatin